Sukhatme Mayukh bought ROIV
August 18, 2026 · Form 4 insider transaction
Sukhatme Mayukh bought 31,801 shares of Roivant Sciences Ltd. at $3.85 per share, a transaction worth $122.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
31,801
Price
$3.85
Total value
$122.4K
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 18, 2026
Shares owned after18,662,540
OwnershipDirect
10b5-1 planNo
AmendedNo